Delivery Order SPE2DB24D2205-SPE2DB24FDUJT
- Not listed
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $25,162.65, is for the delivery of MONOVISC 88 MG/4 ML SYRINGE 4ML, a medical product, with an ultimate completion date of October 31, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) worth $999,999,999 that AmerisourceBergen holds with the DLA Troop Support...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $11,767.52, is for the delivery of MONOVISC 88 MG/4 ML SYRINGE 4ML, a medical product. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of MONOVISC 88 MG/4 ML SYRINGE 4ML, a medical product, with a ceiling value of $4,242.33 and a period of performance through November 12, 2024. This delivery order is under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support...
- This federal contract award, valued at $10,567.98, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MONOVISC 88 MG/4 ML SYRINGE 4ML, a medical product, with a completion date of June 25, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract award, valued at $4,905.57, is for the delivery of MONOVISC 88 MG/4 ML SYRINGE 4ML, a medical product. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of MONOVISC 88 MG/4 ML SYRINGE 4ML, a medical product, with a ceiling value of $10,198.01. The contract is a Delivery Order with a Firm Fixed Price pricing type, set to expire on November 1, 2023. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of MONOVISC 88 MG/4 ML SYRINGE 4ML, a medical product, with a ceiling value of $4,905.57 and an ultimate completion date of May 9, 2023. The contract is a Delivery Order with a Firm Fixed Price pricing type. This award is associated with a larger Indefinite Delivery Contract (IDC) that...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of MONOVISC 88 MG/4 ML SYRINGE 4ML medical supplies, with a ceiling value of $15,377.81 and a completion date of October 29, 2024. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and is not designated with a set-aside. Amerisourcebergen holds a significant Indefinite...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,567.40, is for the delivery of MONOVISC 88 MG/4 ML SYRINGE 4ML, a medical product, with a completion date of February 10, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $25,561.67 and is for the delivery of MONOVISC 88 MG/4 ML syringes. The contract is a firm-fixed-price delivery order with a completion date of February 11, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB24FDUJTDelivery Order
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MONOVISC 88 MG/4 ML SYRINGE 4ML, a medical product, with a ceiling value of $9,423.32 and a period of performance ending on May 21, 2024. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.4k | 5/20/24 |